Intellia Therapeutics (NTLA) Operating Margin (QoQ) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Intellia Therapeutics 1.63 Bn 1.63 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -23,922.00
Dec 31, 2025 38,000.00
Sep 30, 2025 -3,669.00
Jun 30, 2025 -4,560.00
Mar 31, 2025 33,329.00
Dec 31, 2024 52,909.00
Sep 30, 2024 40,965.00
Jun 30, 2024 -160,461.00
Mar 31, 2024 -769,144.00
Dec 31, 2023 839,073.00
Sep 30, 2023 -11,981.00
Jun 30, 2023 -8,534.00
Mar 31, 2023 -7,706.00
Dec 31, 2022 -1,558.00
Sep 30, 2022 -9,484.00
Jun 30, 2022 58,131.00
Mar 31, 2022 -65,636.00
Dec 31, 2021 2.34 Mn
Sep 30, 2021 -2.29 Mn
Jun 30, 2021 -33,337.00
Mar 31, 2021 -7,743.00
Dec 31, 2020 -51,642.00
Sep 30, 2020 7,665.00
Jun 30, 2020 45,784.00
Mar 31, 2020 -38,873.00
Dec 31, 2019 -3,365.00
Sep 30, 2019 840.00
Jun 30, 2019 -1,878.00
Mar 31, 2019 3,507.00
Dec 31, 2018 6,204.00
Sep 30, 2018 -1,796.00
Jun 30, 2018 -704.00
Mar 31, 2018 7,034.00
Dec 31, 2017 -15,369.00
Sep 30, 2017 5,373.00
Jun 30, 2017 -6,236.00
Mar 31, 2017 -1,601.00
Dec 31, 2016 -3,424.00
Sep 30, 2016 706.00
Jun 30, 2016 21,156.00
Mar 31, 2016 -5,237.00
Dec 31, 2015 -12,878.00
Sep 30, 2015 5,295.00
Jun 30, 2015 -15,559.00